
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Marina Kremyanskaya, MD PhD
Internal Medicine, Hematology-Oncology, Cancer (Oncology)
About Me
Marina Kremyanskaya, MD, PhD, is Associate Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai. She serves as Chief Quality Officer at the Mount Sinai Tisch Cancer Center. As such, she oversees efforts to advance clinical quality, patient safety, and operational excellence across cancer care delivery sites throughout the Mount Sinai Health System. She leads initiatives designed to strengthen a unified culture of quality and ensure safe, evidence-based, and patient-centered oncology care. Previously, Dr. Kremyanskaya served as Medical Director of the Inpatient Hematologic Malignancies Services at The Mount Sinai Hospital.
Dr. Kremyanskaya’s clinical focus is on acute myeloid leukemia (AML) and other myeloid malignancies such as myeloproliferative neoplasm (MPN), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), and other myeloid blood cancers.
Dr. Kremyanskaya works as a part of a multidisciplinary team to provide high quality, patient-centered care and to ensure the best possible outcomes. Dr. Kremyanskaya is actively involved in the development of novel therapies for patients with MPN and AML and is leading numerous clinical trials investigating better treatment options for these relatively rare conditions. She has authored multiple peer-reviewed publications and book chapters.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Leukemia
Clinical Focus
- Acute Myeloid Leukemia
- Blood Transfusion
- Bone Marrow Biopsy
- Cancer Treatment
- Chemotherapy
- Essential Thrombocythemia
- Hematologic Malignancies
- Hematology
- Leukemia
- Leukocytosis / High White Blood Count
- Myelodysplastic Syndromes
- Myelofibrosis
- Myeloproliferative Disorders
- Polycythemia Vera
- Thrombocytosis / High Platelets
Education
MD, Perelman School Of Medicine At The University Of Pennsylvania
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Hematology & Oncology
Mount Sinai Hospital
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- 32BJ Health Fund
- AETNA - Commercial
- AETNA - Medicare
- Amidacare Medicaid
- Anthem/Empire Blue Cross Blue Shield - Commercial
- Anthem/Empire Blue Cross Blue Shield - HealthPlus Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - UMR Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms. Charles Hertz, Nikolaos Spyrou, Ronald Hoffman, Cansu Cimen Bozkus, Nina Bhardwaj, Douglas Tremblay, Marina Kremyanskaya, John Mascarenhas. Leukemia
- Modulators of the hepcidin pathway in polycythemia vera and myelofibrosis. Marina Kremyanskaya, Yelena Z. Ginzburg, Ronald Hoffman. Blood
- VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy. Andrew T. Kuykendall, Aniket Bankar, Kristen M. Pettit, Joseph Shatzel, Alessandro Lucchesi, Valentín García-Gutiérrez, Jiri Mayer, Abdulraheem Yacoub, Harinder Gill, Daniel Sasca, Joseph M. Scandura, Marina Kremyanskaya, David M. Ross, Francesca Palandri, Maria Laura Fox, Alessandro Maria Vannucchi, Tamanna Haque, Steffen Koschmieder, Jean Jacques Kiladjian, Pedro Oyuela, Phillip Dinh, Jie Xiao, Frank H. Valone, Suneel Gupta, Sarita Khanna, Arturo Molina, Naveen Pemmaraju, Perkins, Andrew Perkins, David M. Ross, Peter Tan, Albert Woelfler, Clemens Schmitt, Daniel Lechner-Radner, Veronika Buxhofer-Ausch, Dominiek Mazure, Nikki Granacher, Timothy Devos, Aniket Bankar, Mauricio Chandia, Anna Jonasova, Antonin Hlusi, Jiri Mayer, Annalisa Andreoli, Fiorenza Barraco, Françoise Boyer, Jean Jacques Kiladjian, Yuriy Drebit, Adrian Schwarzer, Daniel Sasca, Thomas Illmer, Philipp Le Coutre, Steffen Koschmieder, Thomas Wolff, Gill Harinder Singh, Arpad Illes, Balázs Tajti, Adi Shacham Abulafia, Ilya Kirgner, Martin H. Ellis, Eran Zimran, Alessandro Isidori, Alessandro Lucchesi, Alessandro Morotti, Alessandro Maria Vannucchi, Alessandro Rambaldi, Elisa Rumi, Francesca Palandri, Giulia Benevolo, Valerio De Stefano, Oscar Eduardo Castellanos Velazco, Gabriela Cesarman, Peter Westerweel, Peter te Boekhorst, Andrzej Mital, Jacek Krzanowski, Jaroslaw Czyz, Tadeusz Robak, Justyna Rybka, Marcin Rymko, Alberto Alvarez, Blanca Xicoy Cirici, Pilar Giraldo, Valentin Garcia-Gutierrez, Maria Laura Fox, Patricia Velez Tenza, Rosa Ayala Diaz, Santiago Osorio Prendes, Fahri Sahin, Mehmet Yilmaz, Munci Yagci, Pervin Topcuoglu, Ciro Rinaldi, Julie Glanville, Richard Kaczmarski, Samah Alimam, Bruce Bank, Christopher Benton, Juan Cattoni, Swarna Chanduri, Michael Choi, Nashat Gabrail, Swati Goel, Jason Gotlib, Carl Gray, Anna Halpern, Tamanna Haque, Marina Kremyanskaya, Andrew T. Kuykendall, Andrew Leavitt, Darla Liles, Jennifer Lucas, Craig Maguire, Brandon McMahon, Nicolaos Palaskas, Naveen Pemmaraju, Kristen Pettit, Victor Priego, Amol Rakkar, Lindsay Rein, Joseph Scandura, Jamile Shammo, Joseph Shatzel, Jason Tache, Jennifer Vaughn, Lindsay Wilde, Abdulraheem Yacoub. Journal of Clinical Oncology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Kremyanskaya during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services
Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership- Silence Therapeutics
- Kura Oncology
- Agios
- Disc Medicine, Inc.
- Takeda Pharmaceuticals Of North America, Inc.
- Incyte Corporation
- PharmaEssentia
- Protagonist Therapeutics, Inc
- Cogent Biosciences
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.